Hi - thanks for this.
Can I ask in what sense were you unimpressed with the Phase 2 results? They seem pretty positive to me.
Do you have some estimate of the 'huge cost' of running a Phase 3 trial - I can't find any data on this. CSL is now a pretty substantial company, so I would have thought that this sort of thing would be unlikely to stretch the balance sheet.
Cheers
PZ
Hi - thanks for this. Can I ask in what sense were you...
-
- There are more pages in this discussion • 900 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$309.72 |
Change
0.430(0.14%) |
Mkt cap ! $149.6B | |||
| Open | High | Low | Value | Volume |
| $310.10 | $311.54 | $308.61 | $295.6M | 953.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14819 | $309.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $310.00 | 36 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |